Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Human Molecular Genetics|October 2, 2002
Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in micePatrizia D'Adamo, Hans Welzl, Stavros Papadimitriou, et al.Molecular Neurobiology|November 8, 2018
A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett SyndromeAnna Gandaglia, Elena Brivio, Sara Carli, et al.Scientific Reports|October 8, 2016
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficitsValentina Zamboni, Maria Armentano, Gabriella Sarò, et al.Brain : a Journal of Neurology|September 26, 2012
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicityErica Butti, Marco Bacigaluppi, Silvia Rossi, et al.Nature Communications|December 9, 2022
Neural precursor cells tune striatal connectivity through the release of IGFBPL1Erica Butti, Stefano Cattaneo, Marco Bacigaluppi, et al.Science Immunology|November 23, 2021
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasionValeria Fumagalli, Micol Ravà, Davide Marotta, et al.American Journal of Human Genetics|February 18, 2010
Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephalyMaila Giannandrea, Veronica Bianchi, Maria Lidia Mignogna, et al.Metabolism: Clinical and Experimental|December 14, 2020
Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mousePatrizia D'Adamo, Anemari Horvat, Antonia Gurgone, et al.Scientific Reports|January 12, 2017
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patientsAisha V Sauer, Raisa Jofra Hernandez, Francesca Fumagalli, et al.Disease Models & Mechanisms|March 5, 2026
Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone diseaseMargherita Berti, Selene Ceriotti, Ludovica Santi, et al.Pageof 5